These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34626409)

  • 1. Methods for Assessing the Effects of Xylosides on Angiogenesis.
    Chua JS; Muruganandam G; Saijoh Y; Balagurunathan K
    Methods Mol Biol; 2022; 2303():595-603. PubMed ID: 34626409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Xylosides: Probing the Glycosaminoglycan Biosynthetic Machinery for Biomedical Applications.
    Chua JS; Kuberan B
    Acc Chem Res; 2017 Nov; 50(11):2693-2705. PubMed ID: 29058876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium(II)- and copper(I)-catalyzed synthesis of click-xylosides and assessment of their glycosaminoglycan priming activity.
    Mencio CP; Garud DR; Doi Y; Bi Y; Vankayalapati H; Koketsu M; Kuberan B
    Bioorg Med Chem Lett; 2017 Nov; 27(22):5027-5030. PubMed ID: 29033235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Click'-xylosides as initiators of the biosynthesis of glycosaminoglycans: Comparison of mono-xylosides with xylobiosides.
    Chatron-Colliet A; Brusa C; Bertin-Jung I; Gulberti S; Ramalanjaona N; Fournel-Gigleux S; Brézillon S; Muzard M; Plantier-Royon R; Rémond C; Wegrowski Y
    Chem Biol Drug Des; 2017 Mar; 89(3):319-326. PubMed ID: 27618481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and assessment of glycosaminoglycan priming activity of cluster-xylosides for potential use as proteoglycan mimetics.
    Tran VM; Nguyen TK; Sorna V; Loganathan D; Kuberan B
    ACS Chem Biol; 2013 May; 8(5):949-57. PubMed ID: 23402705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biomedical applications of xylosides.
    Kalita M; Quintero MV; Raman K; Tran VM; Kuberan B
    Methods Mol Biol; 2015; 1229():517-28. PubMed ID: 25325977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of fluorophore-tagged xylosides that prime glycosaminoglycan chains.
    Tran VM; Kuberan B
    Bioconjug Chem; 2014 Feb; 25(2):262-8. PubMed ID: 24499349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Screening of α-Xylosides in Human Glioblastoma Cells.
    Kalita M; Villanueva-Meyer J; Ohkawa Y; Kalyanaraman C; Chen K; Mohamed E; Parker MFL; Jacobson MP; Phillips JJ; Evans MJ; Wilson DM
    Mol Pharm; 2021 Jan; 18(1):451-460. PubMed ID: 33315406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel cytoskeletal action of xylosides.
    Mencio CP; Tilve SM; Suzuki M; Higashi K; Katagiri Y; Geller HM
    PLoS One; 2022; 17(6):e0269972. PubMed ID: 35763520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis.
    Lugemwa FN; Esko JD
    J Biol Chem; 1991 Apr; 266(11):6674-7. PubMed ID: 2016281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of synthesis of free chondroitin sulfate chains by beta-D-xylosides in cultured cells.
    Schwartz NB; Galligani L; Ho PL; Dorfman A
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):4047-51. PubMed ID: 4372604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure.
    Fritz TA; Lugemwa FN; Sarkar AK; Esko JD
    J Biol Chem; 1994 Jan; 269(1):300-7. PubMed ID: 8276811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual beta-D-xylosides that prime glycosaminoglycans in animal cells.
    Lugemwa FN; Sarkar AK; Esko JD
    J Biol Chem; 1996 Aug; 271(32):19159-65. PubMed ID: 8702593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel glycosaminoglycan biosynthetic inhibitors affect tumor-associated angiogenesis.
    Raman K; Ninomiya M; Nguyen TK; Tsuzuki Y; Koketsu M; Kuberan B
    Biochem Biophys Res Commun; 2011 Jan; 404(1):86-9. PubMed ID: 21094131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the elusive mechanism of glycosaminoglycan biosynthesis.
    Victor XV; Nguyen TK; Ethirajan M; Tran VM; Nguyen KV; Kuberan B
    J Biol Chem; 2009 Sep; 284(38):25842-53. PubMed ID: 19628873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-deoxy-4-fluoro-xyloside derivatives as inhibitors of glycosaminoglycan biosynthesis.
    Tsuzuki Y; Nguyen TK; Garud DR; Kuberan B; Koketsu M
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7269-73. PubMed ID: 21074423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of heparan sulfate and chondroitin sulfate proteoglycan biosynthesis.
    Garud DR; Tran VM; Victor XV; Koketsu M; Kuberan B
    J Biol Chem; 2008 Oct; 283(43):28881-7. PubMed ID: 18708345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic and glycosaminoglycan priming activities of novel 4-anilinequinazoline β-D-xylosides.
    Wang J; Chang Y; Dong X; Zhang R; Tang Y; Zhang M; Yu R; Jiang T; Zhang L
    Carbohydr Res; 2018 Jun; 463():6-13. PubMed ID: 29689449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glycosaminoglycan biogenesis is critical for sensitive-period-dependent vocal ontogeny.
    Mencio CP; My Tran V; Quintero MV; Koketsu M; Goller F; Kuberan B
    Dev Neurobiol; 2017 Dec; 77(12):1401-1412. PubMed ID: 29055099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of chondroitin sulfate synthesis. Effect of beta-xylosides on synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein.
    Schwartz NB
    J Biol Chem; 1977 Sep; 252(18):6316-21. PubMed ID: 561070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.